Jacobs Levy Equity Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Jacobs Levy Equity Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-67,951	Closed	-$708K	–	1126
2019 Q4	$708K	Sell	67,951 -30,299	-31%	-$220K	0.01%	740
2019 Q3	$386K	Buy	98,250 +85,000	+642%	+$688K	﹤0.01%	752
2019 Q2	$197K	Buy	+13,250	New	+$239K	﹤0.01%	878
2017 Q1	–	Sell	-4,700	Closed	-$209K	–	1035
2016 Q4	$209K	Buy	+4,700	New	+$165K	﹤0.01%	828

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Jacobs Levy Equity Management's CLVS Position: Q1 2020 in Review

Jacobs Levy Equity Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2020, closing a stake of 67,951 shares — an estimated $708K sold.

Jacobs Levy Equity Management first reported a position in CLVS in Q4 2016 and held it in 4 quarters. The position peaked at $708K in Q4 2019. 154 funds tracked by Wall St. Rank hold CLVS as of Q1 2020.

Jacobs Levy Equity Management reported no remaining Clovis Oncology, Inc. position as of Q1 2020 after selling out during the quarter.
Jacobs Levy Equity Management sold 67,951 Clovis Oncology, Inc. shares in Q1 2020, an estimated $708K.
Jacobs Levy Equity Management first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 4 quarters.
Jacobs Levy Equity Management's Clovis Oncology, Inc. position peaked at $708K in Q4 2019.
154 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2020, filed 15 May 2020.